Literature DB >> 7824282

Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile.

O Kranenburg1, R P de Groot, A J Van der Eb, A Zantema.   

Abstract

The retinoblastoma gene product (pRb) is essential for normal embryonic development. Phosphorylation of pRb by cyclin dependent kinases (cdk's) is believed to be crucial for the regulation of its function. In this report we have studied the regulation of pRb and cdk's during in vitro differentiation of P19 embryonal carcinoma (EC) cells, as a model for early developmental processes. During EC cell differentiation, the synthesis of pRb is strongly induced. In addition, the phosphorylation state of induced pRb is modulated, yielding mainly underphosphorylated pRb. Concomitantly, the pRb kinases cdk2 and cdk4 are differentially regulated: cdk2 kinase activity is impaired, whereas cdk4 kinase activity is stimulated, due to an induction of cyclins D1 and D2. Furthermore, the DNA binding activity of E2F transcription factors is strongly impaired during differentiation and the number of cells in G1 is increased. Thus, P19 EC cell differentiation is accompanied by changes in cdk-activities, pRb regulation and E2F DNA-binding, resulting in the generation of cell types with an altered cell cycle profile.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7824282

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Assessment of protein expression levels after transient global cerebral ischemia using an antibody microarray analysis.

Authors:  Maria Irene Ayuso; Lidia García-Bonilla; Maria Elena Martín; Matilde Salinas
Journal:  Neurochem Res       Date:  2010-05-11       Impact factor: 3.996

2.  PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

Authors:  S Altiok; M Xu; B M Spiegelman
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

3.  Cell cycle features of primate embryonic stem cells.

Authors:  Anne-Catherine Fluckiger; Guillaume Marcy; Mélanie Marchand; Didier Négre; François-Loïc Cosset; Shoukhrat Mitalipov; Don Wolf; Pierre Savatier; Colette Dehay
Journal:  Stem Cells       Date:  2005-10-20       Impact factor: 6.277

4.  Cytoplasmic initiation of cisplatin cytotoxicity.

Authors:  Fang Yu; Judit Megyesi; Peter M Price
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-09

5.  Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.

Authors:  M Meyyappan; H Wong; C Hull; K T Riabowol
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

6.  A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis.

Authors:  G Gil-Gómez; A Berns; H J Brady
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

7.  c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition.

Authors:  J Bash; W X Zong; C Gélinas
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

8.  Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2.

Authors:  Peter M Price; Fang Yu; Philipp Kaldis; Eiman Aleem; Grazyna Nowak; Robert L Safirstein; Judit Megyesi
Journal:  J Am Soc Nephrol       Date:  2006-08-16       Impact factor: 10.121

9.  Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

Authors:  A McShea; P L Harris; K R Webster; A F Wahl; M A Smith
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 10.  Cell cycle control of embryonic stem cells.

Authors:  Josephine White; Stephen Dalton
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.